SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-21-014759
Filing Date
2021-06-21
Accepted
2021-06-21 06:17:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 forms-3a.htm S-3/A 89179
  Complete submission text file 0001493152-21-014759.txt   90445
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-256790 | Film No.: 211027209
SIC: 7389 Services-Business Services, NEC